
Low Fasting Insulin Does Not Exclude Elevated Apolipoprotein B: A Real-World Primary Care Study
To download and read the full paper check out https://www.irondpc.com/blog
To learn HRT go to HRTPCP.com
Abstract
Background
Insulin resistance and elevated apolipoprotein B (ApoB) frequently coexist in adverse cardiometabolic phenotypes. However, biologic association does not establish that fasting insulin and ApoB provide interchangeable clinical information. Whether individuals with low fasting insulin reliably demonstrate low ApoB in routine primary care remains uncertain.
Objective
To characterize the relationship and discordance between fasting insulin and ApoB among adults undergoing same-day testing in a real-world primary care population, with secondary analyses incorporating hemoglobin A1c and exploratory analyses of female age, LC-MS estradiol, and ApoB.
Methods
We conducted a retrospective observational analysis of routinely collected laboratory data from a community-based primary care practice. The primary cohort included adults aged 18 years or older with numeric ApoB and explicitly fasting insulin measurements obtained on the exact same collection date. Each patient contributed the first chronologically qualifying paired measurement to the primary analysis. The primary outcome was the Spearman correlation between fasting insulin and ApoB. Secondary analyses assessed ApoB prevalence across fasting-insulin quartiles and multivariable associations adjusted for age and sex. Hemoglobin A1c was incorporated as an additional glycemic covariate in participants with same-day measurements. An exploratory female analysis evaluated exact same-day LC-MS estradiol and ApoB measurements.
Results
The primary cohort included 365 adults (62.7% male; mean age 48.0 plus or minus 13.0 years). Mean ApoB was 100.9 plus or minus 28.6 mg/dL, and median fasting insulin was 7.7 (IQR 5.1 to 12.6). Fasting insulin and ApoB were positively but weakly correlated (Spearman rho = 0.156; p = 0.0029). After adjustment for age and sex, each doubling of fasting insulin was associated with 4.19 mg/dL higher ApoB (95% CI 1.46 to 6.93; p = 0.0028).
Despite this association, substantial discordance was observed. Among participants in the lowest fasting-insulin quartile, 59.8% had ApoB of 90 mg/dL or higher and 44.6% had ApoB of 100 mg/dL or higher.
Hemoglobin A1c was available on the same date in 347 participants (95.1%). After additional adjustment for A1c, each doubling of fasting insulin remained associated with 3.47 mg/dL higher ApoB (95% CI 0.66 to 6.28; p = 0.015). Among 79 adults with both A1c less than 5.7% and fasting insulin in the lowest quartile, 60.8% had ApoB of 90 mg/dL or higher and 46.8% had ApoB of 100 mg/dL or higher.
In an exploratory analysis of 133 adult women with exact same-day ApoB and LC-MS estradiol measurements, estradiol was modestly inversely associated with ApoB in unadjusted analysis (Spearman rho = -0.182; p = 0.036), but this association was attenuated after adjustment for age.
Conclusions
Fasting insulin was positively but weakly associated with ApoB in this real-world primary care population. Elevated ApoB remained common among patients with low fasting insulin, including patients who simultaneously had A1c less than 5.7%. These findings suggest that fasting insulin, chronic glycemia, and ApoB provide overlapping but substantially nonredundant information. Exploratory female analyses demonstrated opposing age-related trajectories of estradiol and ApoB, although a single contemporaneous estradiol measurement did not independently explain ApoB after adjustment for age.
Keywords: apolipoprotein B; ApoB; fasting insulin; hemoglobin A1c; insulin resistance; estradiol; cardiometabolic risk; primary care; discordance
More episodes from "Iron Direct Primary Care Podcast"



Don't miss an episode of “Iron Direct Primary Care Podcast” and subscribe to it in the GetPodcast app.








